financetom
Business
financetom
/
Business
/
Senate committee may subpoena US Army for helicopter safety memo
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Senate committee may subpoena US Army for helicopter safety memo
Apr 2, 2025 9:14 AM

WASHINGTON, April 2 (Reuters) -

The Senate Commerce Committee may subpoena the U.S. Army to

obtain a report detailing why it routinely failed to use a

safety system known as ADS-B on helicopter flights around Reagan

Washington National Airport, its chair said on Wednesday.

An army Black Hawk helicopter did not have the system

operating during a routine training mission when it collided

with an American Airlines ( AAL ) regional jet on January 29

near the airport, killing 67 people.

The army last week refused a request from senators for the

memo.

Committee chair Senator Ted Cruz, a Republican, and Senator

Maria Cantwell, the top Democrat on the panel, had demanded the

army turn over the report by Friday.

Cruz said if the army continued to withhold the document,

the committee planned to issue a subpoena.

"It begs the question, what doesn't the army want Congress

and the American people to know about why it was flying

partially blind?" Cruz said. "This is not acceptable."

The army did not immediately comment Wednesday but said

earlier this week that it would respond directly to the

lawmakers.

ADS-B, or automatic dependent surveillance-broadcast, is an

advanced surveillance technology that transmits an aircraft's

location.

Cruz said if civilians were to die in another collision

between a passenger jet and a Black Hawk helicopter that was not

using the safety system "those deaths will be on the army's

hands."

Civilian airplanes are required to use ADS-B, but the

Federal Aviation Administration in 2019 gave the military an

exemption in rare circumstances. Senators say the military has

rarely if ever used ADS-B in Washington training flights.

The FAA said on Monday it sent notices last week to NASA,

the Justice Department, the Pentagon and Department of Homeland

Security requiring ADS-B use near Reagan National except in

cases such as "active national security missions."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Music streamer Stingray's Q2 revenue beats estimates on higher FAST channel sales
Music streamer Stingray's Q2 revenue beats estimates on higher FAST channel sales
Nov 11, 2025
Overview * Stingray fiscal Q2 revenue grows 21% yr/yr, beating analyst expectations * Adjusted EBITDA for fiscal Q2 beats analyst expectations * Company announces acquisition of TuneIn Holdings to expand digital audio footprint Outlook * Stingray did not provide specific financial guidance for future quarters or full year in press release Result Drivers * FAST CHANNEL SALES - Stingray attributes...
Update: CAE Fiscal Q2 Adjusted Earnings Fall, Revenue Rises; COO to Retire
Update: CAE Fiscal Q2 Adjusted Earnings Fall, Revenue Rises; COO to Retire
Nov 11, 2025
05:43 PM EST, 11/11/2025 (MT Newswires) -- (Updates with organizational changes in the headline and the fifth and sixth paragraphs.) CAE (CAE) reported fiscal Q2 adjusted earnings late Tuesday of CA$0.23 ($0.16), down from CA$0.24 a year earlier. Analysts polled by FactSet expected CA$0.20. Revenue for the quarter ended Sept. 30 was CA$1.24 billion, up from CA$1.14 billion a year...
Metagenomi to Advance Hemophilia A Gene Therapy to Clinical Trials
Metagenomi to Advance Hemophilia A Gene Therapy to Clinical Trials
Nov 11, 2025
05:42 PM EST, 11/11/2025 (MT Newswires) -- Metagenomi ( MGX ) plans to advance its MGX-001 gene therapy for Hemophilia A into clinical development after preclinical data showed curative levels of clotting factor activity in non-human primates. A single-dose treatment restored therapeutically relevant levels of factor VIII, a protein essential for blood clotting, with activity ranging from 17% to 81%...
Label maker CCL's Q3 sales beat estimates
Label maker CCL's Q3 sales beat estimates
Nov 11, 2025
Overview * CCL Industries ( CCLLF ) Q3 sales rose 6.3%, beating analyst expectations * Adjusted EPS for Q3 increased 11% yr/yr, reflecting strong operational performance * Company returned C$155.8 mln to shareholders via dividends and share repurchases Outlook * Company expects modest currency translation tailwind for Q4 2025 earnings * Company well-positioned for global expansion with C$1.1 bln cash-on-hand...
Copyright 2023-2026 - www.financetom.com All Rights Reserved